• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Enanta Pharmaceuticals Inc

+ Add to Watchlist

ENTA:US

38.6900 USD 0.1700 0.44%

As of 20:10:00 ET on 07/30/2014.

Company Profile for Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals Inc. manufactures pharmaceutical products. The Company develops, produces, and markets antibacterial drugs for hepatitis C virus, respiratory tract infections, intravenous, and oral treatments for hospital and community. Enanta Pharmaceuticals offers its products throughout the United States.

Contact Information

Enanta Pharmaceuticals Inc

500 Arsenal Street
Watertown, MA 02472
United States
Phone: 1-617-607-0800
Fax: 1-617-607-0530

Key Executives for Enanta Pharmaceuticals Inc (ENTA)

Jay R LulyPresident/CEONathaniel S Gardiner "Nat"Senior VP/General Counsel
Paul J MellettSenior VP:Finance/CFOTimothy D OcainSenior VP:New Product Strategy
Yat Sun OrSenior VP:R&D/CSOCarol MiceliDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil